105 filings
Page 3 of 6
S-4/A
qm437
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
CORRESP
k23 wwfcz3n
25 Aug 23
Correspondence with SEC
12:00am
SEC STAFF LETTER
7b2o6 rcdr58hbb
16 Aug 23
SEC staff letter
12:00am
UPLOAD
bl8dwfcb08z9xq5w4f
16 Aug 23
Letter from SEC
12:00am
S-4
el7yt2u tw
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
lpl65z95lu6hn98 gn
22 Jun 23
Business combination disclosure
9:12am
8-K
2myipl
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am
8-K
1zfpvlaersr
14 Jun 23
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
4l2tj7021j06ve
30 May 23
Talaris Therapeutics Announces Leadership Transition
4:51pm
ARS
etbkfy9pdxl
28 Apr 23
Annual report to shareholders
4:30pm
DEFA14A
1ngy4038211tnto
28 Apr 23
Additional proxy soliciting materials
4:08pm
8-K
cgs 47fghry3
14 Apr 23
Cost Associated with Exit or Disposal Activities
5:20pm
S-8
3d1dgk8 nh2zmxjz7hl
31 Mar 23
Registration of securities for employees
4:12pm
8-K
q8ypf8a fy8j7
10 Mar 23
Regulation FD Disclosure
4:03pm
8-K
0tjnahau
16 Feb 23
Talaris Therapeutics Announces Plans to Explore Strategic Alternatives and Implements Restructuring Plan
7:10am